Prosthetic Rehabilitation and Its Influence on Masticatory Performance and QoL in Patients Treated for HNC
Launched by UNIVERSITY OF BARCELONA · Nov 3, 2023
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The adverse effects of oncological treatment can alter both the functional and esthetic capabilities of patients, resulting in a diminished quality of life. Dental rehabilitation with prostheses is used to restore the loss of these parameters. Therefore, it is important to know whether patients treated for head and neck cancer improve their masticatory performance, and therefore their quality of life, when rehabilitated with fixed or removable prostheses.
Masticatory function is altered after oncologic treatment in patients with head and neck cancer, causing a decrease in their quality of ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects over 18 years of age who accept the conditions of the study.
- • Patients diagnosed and treated for head and neck cancer in the stable phase of their oncologic pathology.
- • Patients in need of prosthetic rehabilitation treatment and who agree to be treated.
- Exclusion Criteria:
- • Subjects under 18 years of age and/or who do not accept the conditions of the study.
- • Diagnosis of cancer in regions other than those mentioned in the inclusion criteria.
- • Present a tumor recurrence at the time of the study, undefined oncologic evolutionary situation or under oncologic treatment.
- • Presence of orofacial pain or craniomandibular dysfunction hindering mandibular movement and or participation in the study.
- • Present a disability to complete the different records.
About University Of Barcelona
The University of Barcelona, a prestigious institution renowned for its commitment to research and academic excellence, serves as a leading sponsor for clinical trials aimed at advancing medical knowledge and improving patient outcomes. With a rich history of innovation and collaboration, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research across various fields, including medicine, pharmacology, and public health. Through its robust network of partnerships with healthcare providers and research organizations, the University of Barcelona is dedicated to fostering advancements in clinical practice and contributing to the development of effective therapies and interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
L'hospitalet De Llobregat, Barcelona, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported